Cellular aspects of alpha-fetoprotein reexpression in tumors

Seminars in Cancer Biology

Volumn 9, Issue 2, 1999, Pages 95-107

  Abelev, G I ^a   Eraiser, T L ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Alpha fetoprotein (AFP); Germ cell tumors; Hepatoblast; Hepatoblastoma; Hepatocellular carcinoma; Hepatocyte; Teratocarcinoma; Yolk sac visceral endoderm

Indexed keywords

ALPHA FETOPROTEIN;

CELL TYPE; DEVELOPMENT; ENDODERM; EXTRACELLULAR MATRIX; GERM CELL TUMOR; HEPATOBLASTOMA; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER DEVELOPMENT; LIVER REGENERATION; LIVER TUMOR; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; TERATOCARCINOMA; TUMOR; YOLK SAC;

EID: 0032991680     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1998.0084     Document Type: Article

References (90)

1. Abelev GI. Alpha-fetoprotein: 25 years of study. Tumour Biol. 10:1989;63-74.
2. Abelev GI. Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Adv Cancer Res. 14:1971;295-358.
3. Ruoslahti E, Sëppala M. α-Fetoprotein in cancer and fetal development. Adv Cancer Res. 29:1979;275-346.
4. Deutsch HF. Chemistry and biology of alpha-fetoprotein. Adv Cancer Res. 56:1991;253-212.
5. Abelev GI, Elgort DA. Alpha-fetoprotein. Holland J, Frei E. Cancer Medicine. 1982;1089-1099 Lea and Febiger, New York.
6. Taketa K. α-Fetoprotein: reevaluation in hepatology. Hepatology. 12:1990;1420-1432.
7. McMahon B, London T. Workshop on screening on hepatocellular carcinoma. J Natl Cancer Inst. 83:1991;916-920.
8. Xu K-L. Large-scale AFP-screening for hepatocellular carcinoma in China. Fishman W H. Oncodevelopmental Markers. 1983;395-1408 Academic Press, New York.
9. Schefer H, Mattmann S, Joss RA. Hereditary persistence of alpha-fetoprotein. Case report and review of the literature. Ann Oncol. 9:1998;677-672.
10. Teilum, G, 1976, Special tumors of ovary and testis, Munsgaard, Copenhagen.
11. Dziadek M, Adamson E. Localization and synthesis of alpha-fetoprotein in post-implantation mouse embryos. J Embryol Exp Morphol. 43:1978;289-313.
12. Engelhardt NV, Poltoranina VS, Yazova AK. Localization of alpha-fetoprotein in transplantable murine teratocarcinomas. Int J Cancer. 11:1973;448-459.
13. Nishi S, Nishita T, Ohkawa K. Production of 13 plasma proteins by human testicular yolk sac tumor transplanted into nude mice. Tumor Biol. 12:1991;184-188.
14. Lightner DJ, Longe P. Testicular tumors. Herberman R B, Mercer D W. Immunodiagnosis of Cancer. 1990;397-401.
15. Engelhardt NV, Goussev AI, Shipova LYa, Abelev GI. Immunofluores cent study of α-fetoprotein (αfp) in liver and liver tumours. I. Technique of αfp localization in tissue sections. Int J Cancer. 7:1971;198-206.
16. Eraiser, TL, 1977, Embro-specific gene expression in human hepatocytes, Inst Dev Biol, Moscow.
17. Watabe H. Early appearance of embryonic α-globulin in rat serum during carcinogenesis with 4-dimethylaminazobenzene. Cancer Res. 31:1971;1192-1195.
18. Kroes R, Williams YM, Weisburger JH. Early appearance of serum α-fetoprotein during hepatocarcinogenesis as a function of age of rats and extent of treatment with 3′-methyl-4-dimethylaminobenzene. Cancer Res. 32:1972;1526-1530.
19. Sell S, Becker FF, Leffert HL, Watabe H. Expression of an oncode velopmental gene product (α-fetoprotein) during fetal development and adult oncogenesis. Cancer Res. 36:1976;4239-4249.
20. Iwasaki T, Dempo K, Kaneko A, Onoe T. Fluctuations in various cell populations and their characteristics during azo-dye carcinogenesis. Gann. 63:1972;21-26.
21. Kitagawa T, Yokochi T, Sugano H. α-Fetoprotein and hepatocarcinogenesis in rats fed 3′-methyl-4-(dimethylamino) azobenzene and N -2-fluorenyl-acetate. Int J Cancer. 10:1972;368-381.
22. Sell S. Is there a liver stem cell. Cancer Res. 50:1990;3811-3815.
23. Dempo KN, Chisaka N, Yoshida Y, Kaneko A, Onoe T. Immunofluorescent study on alpha-fetoprotein producing cells in the early stage of 3′-methyl-4-dimethylaminoazobenzene carcinogenesis. Cancer Res. 35:1975;1282-1287.
24. Tchipysheva TA, Guelstein VI, Bannikov GA. Alpha-fetoprotein-containing cells in the early stages of liver carcinogenesis induced by 3′-methyl-4-dimethyl-aminoazobenzene and 2-acetylaminofluorene. Int J Cancer. 20:1977;388-393.
25. Sell S, Hunt JM, Knoll BJ, Dunsford HA. Cellular events during hepatocarcinogenesis in rats and the question of premalignancy. Adv Cancer Res. 48:1987;37-111.
26. Sell S. The role of determined stem-cells in the cellular lineage of hepatocellular carcinoma. Int J Dev Biol. 37:1993;189-201.
27. Faris RA, Hixson DC. Is liver cancer a stem cell-derived disease. Hepatology. 20:1994;1368-1370.
28. Yavorkovsky L, Lai E, Ilic Z, Sell S. Participation of small int raportal stem cells in the restitutive response of the liver to periportal necrosis induced by allyl alcohol. Hepatology. 21:1995;1702-1712.
29. Sell S, Pierce GB. Maturation arrest of stem cell differentiatio n is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest. 70:1994;6-21.
30. Abelev GI, Perova SD, Khramkova NI, Postnikova ZA, Irlin IS. Production of embryonal serum α-globulin by transplantable mouse hepatomas. Transplantation. 1:1963;174-180.
31. Becker JE, de Néchaud B, Potter VR. Two new rat hepatoma cell lines for studying the unbalanced blocked ontogeny hypothesis. Fishman W H, Sell S. Onco-developmental gene expression. 1977;259-270 Acad, New York.
32. 4. I. Reexpression of AFP in differentiated hepatocytes. Histochemistry. 80:1984;401-407.
33. Factor VM, Radaeva SA, Thorgeirsson SS. Origin and fate of oval ce lls in dipin-induced hepatocarcinogenesis in the mouse. Am J Pathol. 145:1994;409-422.
34. Dunsford HA, Sell S, Chisari F. Hepatocarcinogenesis due to chron ic liver injury in hepatitis B transgenic mice. Cancer Res. 50:1990;3400-3407.
35. Engelhardt NV, Factor VM, Medvinsky AL, Baranov VN, Lazareva MN, Poltoranina VS. Common antigen of oval and biliary epithelial cells (A6) is a differentiation marker of epithelial and erythroid cell lineages in early development of the mouse. Differentiation. 55:1993;19-26.
36. Hixson DC, Affigne S, Faris RA, McBride AC. Delineation of antigenic pathways of ethionine-induced liver cancer in the rat. Pathobiology. 64:1996;79-90.
37. Goyette M, Faris R, Braun L, Hixson D, Fausto N. Expression of hepatocyte and oval cell antigens in hepatocellular carcinomas produced by oncogene-transfected liver epithelial cells. Cancer Res. 50:1990;4809-4817.
38. Abelev GI. Experimental study of alpha-fetoprotein re-expression in liver regeneration and hepatocellular carcinomas. Saunder G I. Cell differentiation and neoplasia. 1978;257-268.
39. Gleiberman AS, Kuprina-Khramkova NI, Rudinskaya-Beloshapkina TD, Abele v GI. Alpha-fetoprotein synthesis in relation to structural peculiarities in postnatal and regenerating mouse liver. Int J Cancer. 32:1983;185-192.
40. Moorman AF, de Boer PA, Evans D, Charles R, Lamers WH. Expressio n patterns of mRNAs for alpha-fetoprotein and albumin in the developing rat: the ontogenesis of hepatocyte heteorgeneity. Histochem J. 22:1990;653-660.
41. Notenboom RG, de Boer PA, Moorman AF, Lamers WH. The establishment of the hepatic architecture is a prerequisite for the development of a lobular pattern of gene expression. Development. 122:1996;321-332.
42. Englehardt NV, Poltoranina VS, Lazareva MN, Perova SD, Gleiberman AS. Synthesis and localization of alpha fetoprotein in liver regeneration in mice. Biull Eksp Biol Med (. 10:1976;1251-1254.
43. 4. I. Reexpression of AFP in differentiated hepatocytes. Histochemistry. 80:1984;401-407.
44. Dabeva MD, Shafritz DA. Activation, proliferation and differentiation of progenitor cells into hepatocytes in the d -galactosamine model of liver regeneration. Modern Pathol. 7:1994;105-112.
45. Engelhardt NV, Lazareva MN, Abelev GI, Uryvaeva IV, Factor VM, Brodsky VYa. Detection of alpha-fetoprotein in mouse liver differentiated hepatocytes before their progression through S-phase. Nature. 263:1976;146-148.
46. Poltoranina VS. Induction of alpha-fetoprotein synthesis in nonproliferating hepatocytes. Biull Eksp Biol Med (. 2:1981;212-215.
47. Lazareva MN. Alpha-fetoprotein production by the synchronized regenerating murine liver. Its independence on the phases of the mitotic cycle. Oncodev Biol Med. 2:1981;89-99.
48. Leffert H, Moran T, Sell S, Ibsen K, Skelly H, Arias I. Growth state dependent phenotypes of adult hepatocytes in primary monolayer culture. Proc Natl Acad Sci USA. 75:1978;1834-1838.
49. de Néchaud B, Viron A, Puvion E. Monolayer culture of adult mouse hepatic cells secreting albumin and alpha fetoprotein. CR Seances Acad Sci D. 289:1979;737-740.
50. Gleiberman AS. Synthesis of alpha-fetoprotein in primary culture of hepatocytes from adult mice. Biull Eksp Biol Med (. 1:1982;55-58.
51. Poltoranina VS, Sorokina TV. Alpha-fetoprotein synthesis during liver regeneration in adult mice of different strains. Biull Eksp Biol Med (. 7:1978;71-75.
52. de Néchaud B, Uriel J. Transitory cell antigens of rat liver. I. The secretion and synthesis of fetospecific serum proteins during hepatic development and regeneration. Int J Cancer. 8:1971;71-80.
53. Perova SD, Elgort DA, Abelev GI. Alpha-fetoprotein in rat seru m following partial hepatectomy. Biull Eksp Biol Med (. 3:1971;45-47.
54. Sell S, Becker FF. Alphafetoprotein. Cancer Res. 60:1978;19-26.
55. Araki H, Ueda H, Fujimoto S. Immunocytochemical localization of alpha-fetoprotein in the developing and carbon tetrachloride-treated rat liver. Acta Anat (Basel). 143:1992;169-177.
56. Alpini G, Aragona E, Dabeva M, Shafritz DA, Tavoloni N. Distribution of albumin and alpha-fetoprotein messenger RNAs in normal, hyperplastic and preneoplastic rat liver. Am J Pathol. 141:1992;623-632.
57. Watabe J, Leffert H, Sell S. Developmental and maturation changes in alpha-fetoprotein and albumin production by fetal rat hepatocytes in vitro. Fishman W H, Sell S. Oncodevelopmental Gene Expression. 1976;123-130 Academic Press, New York.
58. Henriette M-F, Gabant P, Dreze P-L, Szpizer C, Szpizer J. Negative regulation of the α-fetoprotein gene in fibroblasts: identification and ch aracterization of cis and trans elements. Folia Biol (Praha). 43:1997;5-13.
59. Cassio D, Hassoux R, Dupiers M, Uriel J, Weiss M. Coordinate secr etion of mouse alpha-fetroprotein, mouse albumin and rat albumin by mouse hepatoma - rat hepatoma hybrid cells. J Cell Physiol. 104:1980;295-308.
60. Szpizer J, Szpizer C, Poliard A. Coexistence of expressed and non -expressed α-fetoprotein genes in somatic cell hybrids. Exp Cell Res. 146:1983;224-229.
61. Gleiberman AS, Trojanovskii SM, Bannikov GA. Cytoskeletal reorganization in hepatocytes of the regenerating mouse liver. Biull Eksp Biol Med (. 12:1984;741-743.
62. Gleiberman AS, Abelev GI. Cell position and cell interactions in expression of fetal phenotype of hepatocyte. Int Rev Cytol. 95:1985;229-266.
63. Glieberman AS, Kudrjavtseva EI, Sharovskaya YuYu, Abelev GI. Synthesis of alpha-fetoprotein in hepatocytes is co-ordinately regulated with cell-cell and cell-matrix interactions. Mol Biol Med. 6:1989;95-107.
64. Gleiberman AS, Sharovskaya YuYu, Chailakhjan LM. 'Contact inhibition' of alpha-fetoprotein synthesis and junctional communication in adult mouse hepatocyte culture. Exp Cell Res. 184:1989;228-234.
65. Kudrjavtseva EI. Extracellular matrix is important factor for tissue-specific hepatocyte organization. Eur J Cell Biol. 74:1997;47-46.
66. Musat AI, Sattler CA, Sattler GL, Pitot HC. Reestablishment of cell polarity of rat hepatocytes in primary culture. Hepatology. 18:1993;198-205.
67. Reid LM. Stem cell biology, hormone/matrix synergies and liver differentiation. Curr Opin Cell Biol. 2:1990;121-130.
68. Maher JJ, Bissel DM. Cell-matrix interactions in liver. Sem Cell Biol. 4:1993;189-201.
69. Couvelard A, Bringuier A-F, Dauge M-C, Nejjari M, Darai E, Benifla J-L, Feldmann G, Henin D, Socazec J-Y. Expression of integrins during liver organogenesis in humans. Hepatology. 26:1998;839-847.
70. Michalopoulos MO, DeFrance A. Liver regeneration. Science. 276:1997;60-66.
71. Farber E. Precancerous steps in carcinigenesis: their physiological adaptive nature. Biochem Biophys Acta. 738:1984;171-180.
72. Bannasch P. Sequential cellular changes during chemical carcinogensis. Cancer Res Clin Oncol. 108:1984;11-22.
73. Nakabaysahi H, Hashimoto T, Miyao Y, Tjong KK, Chan J, Tamaoki T. A position-dependant silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma. Mol Cell Biol. 11:1991;5885-5893.
74. Khramkova NI, Guelstein VI. Antigenic structure of mouse hepatomas. Organospecific liver antigens and embryonic α-globulin in hepatomas of mice induced with orthoaminoazotoluene (AAT). Neoplasma. 12:1965;239-250.
75. Shipova LYa, Glieberman AS. AFP-synthesis induction in mouse hepatomas. Int J Cancer. 35:1985;135-138.
76. Masseyeff R. Human alpha-fetoprotein (review). Pathol Biol. 20:1972;703-727.
77. Sell S, Morris P. Relationship of rat α-fetoprotein to growth rate and chromosomal composition of Morris hepatomas. Cancer Res. 34:1974;1413-1417.
78. Irlin IS, Perova SD, Abelev GI. Changes in the biological and bio chemical properties of mouse hepatoma during long-term cultivation in vitro. Int J Cancer. 1:1966;337-347.
79. Eraiser TL, Khamsina LS. Phenotypic variability of cultured rat h epatoma cell population in respect to alpha-fetoprotein synthesis. Int J Cancer. 42:1988;633-637.
80. Chaya D, Fougere-Deschatrette C, Weiss MC. Liver-enriched transcription factors uncoupled from expression of hepatic functions in hepatoma cell lines. Mol Cell Biol. 17:1997;6311-6320.
81. Bulla GA. Hepatocyte nuclear factor-4 prevents silencing of hepatocyte nuclear factor-1 expression in hepatoma × fibroblast cell hybrids. Nucleic Acids Res. 25:1997;2501-2508.
82. Späth GF, Weiss MC. Hepatocyte nuclear factor 4 expression ov ercomes repression of the hepatic phenotype in dedifferentiated hepatoma cells. Mol Cell Biol. 17:1997;1913-1922.
83. Lazarevich NL, Kudrjavtseva EI, Varga EV, Morozova OV, Cheremnova OA, Ovchinnikov DA, Shapiguzov AY, Turusov VS, Engelhardt NV. Expression of liver-specific and hepatocyte nuclear factors in the new model of low- and fast-growing transplantable mouse hepatomas. FASEB Summer Research Conference 'Mechanisms of Liver Growth and Differentiation in Health and Disease', Snowmass, Colorado USA. Abstract book. 1998;. p. 1-22.
84. Späth GF, Weiss MC. Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol. 140:1998;935-946.
85. Ohguchi S, Nakatsugase H, Higashi T, Ashida K, Nouso K, Ishizaki M, Hino N, Kobayashi Y, Uematsu Sh, Tsuyi T. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinoma: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy. Hepatology. 28:1998;599-607.
86. Kuprina NI, Savushkina NK, Andreev AV, Gleiberman AS. The modulation of the phenotype of the human hepatoblastoma cell line HepG2 under the action of dimethyl sulfoxide. Onotogenez. 24:1993;57-67.
87. Cook JR, Schwartz CE, Faussel ED, Chiu JF. Effect of sodium butyrate on alpha-fetoprotein gene expression in rat hepatoma cells in vitro. Cancer Res. 45:1985;3215-3219.
88. Tsutsumi T, Ido A, Nakao K, Hamasaki K, Kato Y, Ohturu A, Nakata K, Tamaoki T, Nagataki S. Reciprocal regulation of alpha-fetoprotein and albumin gene expression by butirate in human hepatoma cells. Gastroenterology. 107:1994;499-504.
89. Huang DP, Schwarts SE, Chin JF, Coon JR. Dexamethaxone inhibition of rat hepatoma growth and alpha-fetoprotein synthesis. Cancer Res. 44:1984;2976-2980.
90. Eraiser TL, Yazova AK, Poltoranina VS, Kuprina NI, Karomova ER, Shipova LY, Lazarevich NL, Abelev GI. Inducible protein in rat hepatomas with expression alternative to alpha-fetoprotein. Int J Cancer. 75:1998;371-378.